Viewing Study NCT04184895


Ignite Creation Date: 2025-12-24 @ 2:14 PM
Ignite Modification Date: 2026-01-03 @ 8:18 PM
Study NCT ID: NCT04184895
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-27
First Post: 2019-12-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Safety, Tolerability and Immunological Response of ASP2390 in Adult Subjects Allergic to House Dust Mites
Sponsor: Astellas Pharma Global Development, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-09-09
Start Date Type: ACTUAL
Primary Completion Date: 2022-12-22
Primary Completion Date Type: ACTUAL
Completion Date: 2026-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2019-12-02
First Submit QC Date: None
Study First Post Date: 2019-12-04
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-10-24
Last Update Post Date: 2025-10-27
Last Update Post Date Type: ESTIMATED